Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Big business is high on the Honolulu method

Article Abstract:

ProBio America Inc. will provide $1 million to the Honolulu, Hawaii laboratory where University of Hawaii researchers cloned 50 mice from adult cells. The company, a US subsidiary of the Australian company ProBio Limited, has financed the lab to advance animal cloning and freeze-dried sperm technology. In return for its financial outlay, ProBio will get access to international licensing rights for future biomedical or pharmaceutical products developed by the University of Hawaii researchers. Through this arrangement, the university and researcher Ryuzo Yanagimachi will receive as much as 50% of net proceeds for 20 years, including 8% of net sales and 25% of licensing revenue and payouts for milestones such as use of their cloning technology for commercial useful animals like cows.

Comment:

ProBio America grants $1mil to Hawaii lab that cloned 50 mice from adult cells

Author: Hoyle, Russ
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1998
United States, Research & development outlays, ProBio America Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A freeze-dryer and a fertile imagination

Article Abstract:

Mouse sperm has proved to be much more resilient than formerly imagined. Authors Wakayama and Yanagimuchi reported that they freeze-dried mouse sperm, kept it at room temperature for at least three months, reconstituted them with water, and then using intracytoplasmic sperm injection (ICSI) obtain normal embryos and live-born mice. This technique works most effectively when the tail of the sperm is sheared off and has already been applied to human infertility problems where the male suffers from severe oligospermia of has immotile sperm.

Author: Lovell-Badge, Robin
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1998
Science & research, R&D NEC, Research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


GlaxoSmithKline presents a biotech facade

Article Abstract:

GlaxoSmithKline announced that it will restructure its research and development divisions.

Author: Dorey. Emma
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
Parent-to-subsidiary activities, GlaxoSmithKline PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Genetic engineering, Article, United Kingdom
Similar abstracts:
  • Abstracts: Businesses of the future. A legitimate beef? Long live privatization!
  • Abstracts: Acquisitions of solvent thrifts: wealth effects and managerial motivations. Mergers and shareholder wealth in European banking
  • Abstracts: A success by any other name. Are auditors communicating? Ignorance is bliss
  • Abstracts: At home in the dome. Ready for anything. ELO show touch' of success
  • Abstracts: Surfing the problems. And they're off. A surf around the issues
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.